Shareholder Briefcase Registration
Please fill out the form below to sign up for event notifications. Providing this information will allow you to gain full access to our online Investor Relations services. * Required fields
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.